raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:520

Acute promyelocytic leukemia

Synonyms: AML M3 · AML with t(15;17)(q22;q12);(PML/RARalpha) and variants · APML · Acute myeloblastic leukemia 3 · Acute myeloid leukemia with t(15;17)(q22;q12);(PML/RARalpha) and variants

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adolescent, Adult, Childhood, Elderly
Status
active

An aggressive form of acute myeloid leukemia (AML), characterized by arrest of leukocyte differentiation at the promyelocyte stage, due to a specific chromosomal translocation t(15;17) in myeloid cells, and manifests with easy bruising, hemorrhagic diathesis and fatigue.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAcute promyelocytic leukemiaAML M3 · AML with t(15;17)(q22;q12);(PML/RARalpha) and variants · APML · Acute myeloblastic leukemia 3 · Acute myeloid leukemia with t(15;17)(q22;q12);(PML/RARalpha) and variants
frLeucémie aiguë promyélocytaireAML M3 · Leucémie aiguë myéloblastique 3 · Leucémie aiguë myéloïde avec t(15;17)(q22;q12);(PML/RARalpha) et variants
dePromyelozytenleukämie, akuteAML mit t(15;17)(q22;q12);(PML/RARalpha) und Varianten · AML-M3 · APML · Akute myeloische Leukämie mit t(15;17)(q22;q12);(PML/RARalpha) und Varianten · Leukämie, akute myeloische, Typ 3
esLeucemia promielocítica agudaLMA M3 · LMA con t(15;17)(q22;q12);(PML/RARalpha) y variantes · LPA · Leucemia aguda mieloide con t(15;17)(q22;q12);(PML/RARalpha) y variantes · Leucemia mieloblástica aguda tipo 3 · Leucemia mieloide aguda con t(15;17)(q22;q12);(PML/RARalpha) y variantes
itLeucemia promielocitica acutaAML con t(15;17)(q22;q12);(PML/RARalpha) e varianti · Leucemia mieloblastica acuta, tipo 3 · Leucemia mieloide acuta con t(15;17) (q22;q12); (PML/RARalpha) e varianti · Leucemia mieloide acuta con t(15;17)(q22;q12); (PML/RARalpha) e varianti
nlAcute promyelocytische leukemieAML M3 · AML met t(15;17)(q22;q12);(PML/RARalfa) en varianten · APML · Acute myeloblastische leukemie 3 · Acute myeloïde leukemie met t(15;17)(q22;q12);(PML/RARalfa) en varianten
ptLeucemia promielocítica agudaLeucemia mieloblástica aguda tipo 3
plOstra białaczka promielocytowaAPML · AML M3 · Ostra białaczka mieloblastyczna 3 · AML z t(15;17)(q22;q12);(PML/RARalpha) i wariantami · Ostra białaczka mielocytarna z t(15;17)(q22;q12);(PML/RARalpha) i wariantami
csAkutní promyelocytární leukémieAML M3 · AML s t(15;17)(q22;q12);(PML/RARalpha) a varianty · Akutní myeloblastická leukémie, typ 3 · Akutní myeloidní leukémie s t(15;17)(q22;q12);(PML/RARalpha) a varianty
ukГострий промієлоцитарний лейкозГострий мієлобластний лейкоз 3 · Гострий мієлоїдний лейкоз з t(15;17)(q22;q12);(PML/RARalpha) та варіанти · AML M3 · AML з t(15;17)(q22;q12);(PML/RARalpha) та варіантами · APML
zh急性早幼粒细胞白血病急性早幼粒细胞白血病伴t(15;17)(q22;q12)PML/RARalpha与变异
trAkut promiyelositik lösemiAPML · AML M3 · Akut miyeloblastik lösemi 3 · t(15; 17) (q22; q12); (PML / RARalpha) ve varyantları ile seyreden AML · t(15; 17) (q22; q12); (PML / RARalpha) ve varyantları ile seyreden akut miyeloid lösemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM612376Evalidated
ICD-10C92.4Especificvalidated
ICD-112A60.0NTBTattributedvalidated
ICD-11XH1A50Especificvalidated
MONDO0012883Evalidated
MeSHD015473Evalidated
UMLSC0023487Evalidated
GARD538Evalidated
MedDRA10001019Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

13 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
BCORPart of a fusion gene inAssessedHGNC:20893ENSG00000183337300485Xp11.4BCL6 corepressor20807888[PMID]_25790901[PMID]
FIP1L1Part of a fusion gene inAssessedHGNC:19124ENSG000001452166076864q12factor interacting with PAPOLA and CPSF118603554[PMID]
IRF2BP2Part of a fusion gene inAssessedHGNC:21729ENSG000001682646153321q42.3interferon regulatory factor 2 binding protein 225583766[PMID]_27193600[PMID]
NABP1Part of a fusion gene inAssessedHGNC:26232ENSG000001735596121032q32.3nucleic acid binding protein 123287866[PMID]
NPM1Part of a fusion gene inAssessedHGNC:7910ENSG000001811631640405q35.1nucleophosmin 1
NUMA1Part of a fusion gene inAssessedHGNC:8059ENSG0000013749716400911q13.4nuclear mitotic apparatus protein 19288109[PMID]
PMLPart of a fusion gene inAssessedHGNC:9113ENSG0000014046410257815q24.1PML nuclear body scaffold10942371[PMID]
PRKAR1APart of a fusion gene inAssessedHGNC:9388ENSG0000010894618883017q24.2protein kinase cAMP-dependent type I regulatory subunit alpha17712046[PMID]
RARAPart of a fusion gene inAssessedHGNC:9864ENSG0000013175918024017q21.2retinoic acid receptor alpha10942371[PMID]
STAT3Part of a fusion gene inAssessedHGNC:11364ENSG0000016861010258217q21.2signal transducer and activator of transcription 329237593[PMID]
STAT5BPart of a fusion gene inAssessedHGNC:11367ENSG0000017375760426017q21.2signal transducer and activator of transcription 5B18221386[PMID]
TBL1XR1Part of a fusion gene inAssessedHGNC:29529ENSG000001775656086283q26.32TBL1X/Y related 124782508[PMID]
ZBTB16Part of a fusion gene inAssessedHGNC:12930ENSG0000010990617679711q23.2zinc finger and BTB domain containing 168387545[PMID]_10942371[PMID]
5

Prevalence and incidence

4 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.28 / 100 000United StatesValue and classValidated22707337[PMID]_21653939[PMID]_ ORPHANET
Annual incidence1-9 / 1 000 0000.11 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.3 / 100 000FranceValue and classValidatedOTHERitut National du Cancer 2013[OTHER]
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

36 annotations · validated 2019-05-02
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0001892Abnormal bleeding
HP:0001903Anemia
HP:0002039Anorexia
HP:0031020Bone marrow hypercellularity
HP:0000978Bruising susceptibility
HP:0031035Chronic infection
HP:0005521Disseminated intravascular coagulation
HP:0031364Ecchymosis
HP:0000421Epistaxis
HP:0002875Exertional dyspnea
HP:0012378Fatigue
HP:0001945Fever
HP:0000225Gingival bleeding
HP:0001882Leukopenia
HP:0001324Muscle weakness
HP:0001876Pancytopenia
HP:0000967Petechiae
HP:0000979Purpura
HP:0001873Thrombocytopenia
HP:0002321Vertigo
HP:0001824Weight loss
Occasional (29-5%)
HP:0002027Abdominal pain
HP:0030955Alcoholism
HP:0002653Bone pain
HP:0001875Decreased total neutrophil count
HP:0025420Diffuse alveolar hemorrhage
HP:0000212Gingival overgrowth
HP:0011900Hypofibrinogenemia
HP:0001974Increased total leukocyte count
HP:0002716Lymphadenopathy
HP:0030140Oral cavity bleeding
HP:0031245Productive cough
HP:0010280Stomatitis
Very rare (<4-1%)
HP:0100758Gangrene
HP:0000790Hematuria
HP:0100608Metrorrhagia

Annotation source: 30666067[PMID]_30715157[PMID]_30854206[PMID]_26414475[PMID]_28735889[PMID]

7

Sources for this card